Living meta-analysis and evidence synthesis of therapies for COVID-19

click on circles to display study description...

NCT04429711 (Biber), 2020 NCT04429711

ivermectin (n=100) vs. placebo (n=-9)

randomized controlled trial   some concerns about risk of bias

Studied treatment

ivermectin
12-15mg/ day for 3 days

Control treatment

placebo

Patients

COVID-19 (hospitalized or not)

Method

double blind

1 center, Israel

Remark